Brief: MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
21/10/2025 13:10
Oct 21 (Reuters) - Innovate Corp VATE.N: MEDIBEACON RECEIVES REGULATORY APPROVAL TO SELL THE TRANSDERMAL GFR SYSTEM IN CHINA Source text: ID:nGNX4QVykC Further company coverage: VATE.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innovate
See all newsBrief: Innovate Corp - Enters Tenth Amendment To Credit Agreement With Msd To Extend Maturity To Dec 31, 2026 - SEC Filing
Brief: Innovate Agrees To $650 Million Sale Of Dbm Global To IES Holdings
INNOVATE swings to Q2 profit on higher gross profit and debt extinguishment gains
Brief: INNOVATE Corp. Q2 Revenue USD 421.6 Million
INNOVATE Q1 revenue rises 33%, net loss narrows